Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 15/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | GC | P02774 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5390580 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL5379816 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL7154542 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL5680998 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL5385262 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL25310518 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL5378950 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL8527611 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL7151478 | 1.00 | VDR (0.47) | VDRNR1I2PGRADORA3SLC6A2 | |
| SCHEMBL5382736 | 0.92 | VDR (0.52) | VDRNR1I2PGRADORA3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4866048-A | TREATMENT OF ABNORMAL CALL POLIIFERATION OR DIFFERENTIATION | LEO PHARMACEUTICAL PRODUCTS LTD. (DK) | 1989-09-12 | — | — | US | claimed |
| EP-4611787-A1 | CCR2 INHIBITORS AND METHODS OF USE | Orion Biotechnology USA Corp. (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-3916528-B1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2025-08-20 | — | — | EP | disclosed |
| WO-2025037011-A2 | NOVEL USES | TEITUR TROPHICS APS (DK) | 2025-02-20 | — | — | WO | disclosed |
| EP-4475890-A1 | NOVEL PEPTIDES | Teitur Trophics ApS (DK) | 2024-12-18 | — | — | EP | disclosed |
| US-12171132-B2 | Display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-12-17 | — | — | US | disclosed |
| CN-118804766-A | Novel peptides | 泰图尔特罗菲克斯有限公司 | 2024-10-18 | — | — | CN | disclosed |
| WO-2024094685-A1 | CCR2 INHIBITORS AND METHODS OF USE | ORION BIOTECHNOLOGY HOLDING SA (CH) | 2024-05-10 | — | — | WO | disclosed |
| US-20240099096-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | disclosed |
| US-11871639-B2 | Display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-09 | — | — | US | disclosed |
| WO-2023152229-A1 | NOVEL PEPTIDES | TEITUR TROPHICS APS (DK) | 2023-08-17 | — | — | WO | disclosed |
| CN-116322740-A | Treatment of immunosuppression | 特兰斯吉恩股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20230063211-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-03-02 | — | — | US | disclosed |
| US-11508788-B2 | Display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-11-22 | — | — | US | disclosed |
| CN-111705016-B | Biological agent and preparation method and application thereof | 中国农业科学院烟草研究所 | 2022-04-29 | — | — | CN | disclosed |
| US-7211680-B2 | Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments | SCHERING AKTIENGESELLSCHAFT (DE) | 2007-05-01 | — | — | US | disclosed |
| EP-0617015-B1 | Process for preparing vitamin D3 derivatives and intermediates thereof | HOFFMANN LA ROCHE (CH) | 1997-10-29 | — | — | EP | disclosed |
| US-5411949-A | Control of cell proliferation and differentiation, antitumor, anticancer | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-05-02 | — | — | US | disclosed |
| EP-0617015-A2 | Process for preparing vitamin D3 derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1994-09-28 | — | — | EP | disclosed |